DI BELLA METHOD > DOCUMENTATION INDEX > MDB - Documents

 
 
MDB - Documents
 
 
DOTA-lanreotide: a novel somatostatin analog for tumor diagnosis and therapy. (30/05/2003)
Detail
Two familial giant pituitary adenomas associated with overweight: clinical, morphological and genetic features. (30/05/2003)
Detail
Thymic carcinoma with neuroendocrine differentiation in a calf. (30/05/2003)
Detail
Bilateral chylothorax following neck dissection: a new method of treatment. (30/05/2003)
Detail
Characterization of the 5'-flanking promoter region of the rat somatostatin receptor subtype 3 gene. (30/05/2003)
Detail
Effects of treatment with growth hormone and somatostatin on efficacy of diammine [1,1-cyclobutane dicarboxylato (2-)-0,0']-(SP-4-2) in athymic rats with osteosarcoma. (30/05/2003)
Detail
[Merkel cell carcinoma: a diagnostic and therapeutic challenge] (30/05/2003)
Detail
[Metastatic breast carcinoma with neuroendocrine differentiation--its combined therapy with tamoxifen and the somatostatin analog octreotide] (30/05/2003)
Detail
Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data. (30/05/2003)
Detail
Effects of taurolidine and octreotide on port site and liver metastasis after laparoscopy in an animal model of pancreatic cancer. (30/05/2003)
Detail
Pancreatic cancer: does octreotide offer any promise? (30/05/2003)
Detail
Biokinetics of 111In-DTPA-D-Phe(1)-octreotide in nude mice transplanted with a human carcinoid tumor. (30/05/2003)
Detail
Gastrointestinal cancer refractory to chemotherapy: a role for octreotide? (30/05/2003)
Detail
Low expression of Galpha protein subunits in human prostate cancer. (30/05/2003)
Detail
Bim-23244, a somatostatin receptor subtype 2- and 5-selective analog with enhanced efficacy in suppressing growth hormone (GH) from octreotide-resistant human GH-secreting adenomas. (30/05/2003)
Detail
 
 
 
Scorri con le frecce per visualizzare le pagine della ricerca 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 |
 
 

Stampa